Systemic and Vascular Oxidation Limits the Efficacy of Oral Tetrahydrobiopterin Treatment in Patients With Coronary Artery Disease

BACKGROUND: The endothelial nitric oxide synthase cofactor tetrahydrobiopterin (BH4) plays a pivotal role in maintaining endothelial function in experimental vascular disease models and in humans. Augmentation of endogenous BH4 levels by oral BH4 treatment has been proposed as a potential therapeuti...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Circulation
Autori principali: Cunnington, Colin, Van Assche, Tim, Shirodaria, Cheerag, Kylintireas, Ilias, Lindsay, Alistair C., Lee, Justin M., Antoniades, Charalambos, Margaritis, Marios, Lee, Regent, Cerrato, Ruha, Crabtree, Mark J., Francis, Jane M., Sayeed, Rana, Ratnatunga, Chandi, Pillai, Ravi, Choudhury, Robin P., Neubauer, Stefan, Channon, Keith M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5238935/
https://ncbi.nlm.nih.gov/pubmed/22315282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.111.038919
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi